VG

Venkateshwar Rao Gummadi

AL Aurigene Discovery Technologies Limited: 8 patents #5 of 45Top 15%
NA Novartis Ag: 4 patents #1,111 of 5,128Top 25%
AL Aurigene Oncology Limited: 2 patents #5 of 33Top 20%
Overall (All Time): #310,068 of 4,157,543Top 8%
15
Patents All Time

Issued Patents All Time

Showing 1–15 of 15 patents

Patent #TitleCo-InventorsDate
12428415 Matriptase 2 inhibitors and uses thereof Srikanth Venkatraman, Subhendu Mukherjee, Rajeev Goswami, A. Bharathi Raja, Murtuza Hadianawala 2025-09-30
12410193 Bicyclic heterocyclyl derivatives as IRAK4 inhibitors Susanta Samajdar 2025-09-09
11981685 Bicyclic heterocyclyl derivatives as IRAK4 inhibitors Susanta Samajdar 2024-05-14
11691987 Bicyclic heterocyclyl derivatives as IRAK4 inhibitors Susanta Samajdar 2023-07-04
11419875 Compounds and compositions for treating hematological disorders Susanta Samajdar, Kavitha Nellore, Girish Chandrappa Daginakatte, Wesley R. Balasubramanian 2022-08-23
10995100 Bicyclic heterocyclyl derivatives as IRAK4 inhibitors Susanta Samajdar 2021-05-04
10640517 Bicyclic heterocyclyl derivatives as IRAK4 inhibitors Susanta Samajdar 2020-05-05
10160753 Indazole compounds as IRAK4 inhibitors Susanta Samajdar, Ajay Gupta 2018-12-25
10047104 Bicyclic heterocyclyl derivatives as IRAK4 inhibitors Susanta Samajdar 2018-08-14
9732095 Bicyclic heterocyclyl derivatives as IRAK4 inhibitors Susanta Samajdar 2017-08-15
9353107 3-(pyrazolyl)-1H-pyrrolo[2,3-b]pyridine derivatives as kinase inhibitors Subramanya Hosahalli, Srinivas Nanduri, Girish Aggunda Renukappa 2016-05-31
9339501 17a-hydroxylase/C17,20-lyase inhibitors Mark G. Bock, Christoph Gaul, Saumitra Sengupta 2016-05-17
9029399 17α-hydroxylase/C17,20-lyase inhibitors Mark G. Bock, Christoph Gaul, Saumitra Sengupta 2015-05-12
8946260 17α-hydroxylase/C17,20-lyase inhibitors Mark G. Bock, Christoph Gaul, Henrik Moebitz, Saumitra Sengupta 2015-02-03
8263635 Inhibitors of CYP 17 Mark G. Bock, Christoph Gaul, Saumitra Sengupta 2012-09-11